All Interventions

    PRP Therapy

    Therapies
    Regenerative Therapies

    Concentrated platelet-rich plasma injections to accelerate tissue healing through growth factor delivery.

    Evidence Summary

    7
    / 10Score
    Moderate
    Moderate Evidence

    Moderate-to-strong evidence for orthopedic applications, reinforced by 2025–2026 analyses. A 2026 systematic review and meta-analysis of 62 randomized controlled trials (4,969 patients; International Orthopaedics) found intra-articular PRP produced superior patient-reported pain (VAS) and function (WOMAC) versus hyaluronic acid, corticosteroid, and saline at 6 months, with superiority over hyaluronic acid and corticosteroid maintained to 12 months. A 2025 Bayesian network meta-analysis of ultrasound-guided injections (14 RCTs, 934 patients; Frontiers in Medicine) ranked PRP the highest-probability injectable across WOMAC total, pain, stiffness, and function. Pooled effects are moderate in magnitude (2025 meta-analysis: pain standardized mean difference −0.32, 95% CI −0.48 to −0.15; function −0.28, 95% CI −0.44 to −0.12), structural or disease-modifying benefit remains unproven, and heterogeneity across PRP preparation protocols is high. For rotator cuff repair, a 2025 meta-analysis of randomized trials found leukocyte-poor PRP significantly reduced retear risk (risk ratio 0.54, 95% CI 0.41–0.71; about a 46% relative reduction), though patient-reported gains fell below clinical-importance thresholds, pointing to structural healing as the main benefit. Hair restoration for androgenetic alopecia is supported by a 2025 systematic review of 43 RCTs (1,877 patients; Dermatology and Therapy) and a 2024 meta-analysis showing increased hair density (mean difference +27.55 hairs/cm², 95% CI 14.04–41.06), although effects on hair thickness were not statistically significant. Facial rejuvenation evidence remains preliminary. Across indications, outcomes depend heavily on preparation system and total platelet dose. This is an educational summary of published research, not medical advice.

    Evidence Scale

    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    AnecdotalStrong RCT

    Mechanism of Action

    Platelets release growth factors (PDGF, TGF-β, VEGF, EGF) that stimulate tissue repair, collagen synthesis, angiogenesis, and cellular regeneration.

    Who Is This For?

    Tendon injuries, osteoarthritis, hair loss, facial rejuvenation. Poor response if severe tissue damage.

    Protocol & Dosing

    Dose

    Typically 10–20 mL of blood yields 3–5 mL of PRP; final platelet concentration varies by preparation system. Emerging evidence links a greater delivered platelet dose to better results: a 2026 systematic review and meta-analysis (62 RCTs) found that a total blood-draw volume of at least 40 mL — used as a proxy for platelet dose — was associated with larger 6-month WOMAC and 12-month pain improvements in PRP-versus-hyaluronic-acid knee osteoarthritis trials, underscoring that preparation system and concentration meaningfully affect outcomes.

    Frequency

    Monthly for series

    Duration

    3-6 treatments typical

    Protocol Summary

    Blood drawn, centrifuged to concentrate platelets 3-8x, injected into target tissue.

    Latest Evidence

    2025–2026: largest pooled analyses strengthen the orthopedic case

    A 2026 systematic review and meta-analysis of 62 randomized controlled trials (4,969 patients) reported that intra-articular PRP improved knee-osteoarthritis pain (VAS) and function (WOMAC) more than hyaluronic acid, corticosteroid, and saline at 6 months, with superiority over hyaluronic acid and corticosteroid maintained to 12 months. A 2025 Bayesian network meta-analysis of ultrasound-guided injections (14 RCTs, 934 patients) ranked PRP the highest-probability injectable across every WOMAC domain (chart below). Pooled effect sizes remain moderate (2025 meta-analysis: pain SMD −0.32, 95% CI −0.48 to −0.15), and no analysis has shown structural or disease-modifying benefit — outcomes track closely with preparation system and total platelet dose.

    Beyond the knee, a 2025 meta-analysis of randomized trials found leukocyte-poor PRP lowered rotator-cuff retear risk after arthroscopic repair (risk ratio 0.54, 95% CI 0.41–0.71; ≈46% relative reduction), with structural healing as its main benefit. For androgenetic alopecia, a 2025 review of 43 RCTs (1,877 patients) and a 2024 meta-analysis showed increased hair density (mean difference +27.55 hairs/cm², 95% CI 14.04–41.06), though hair thickness did not improve significantly.

    PRP is autologous and generally well tolerated, but preparation protocols, platelet dose, and leukocyte content vary widely between systems and affect results. This is an educational summary of published research, not medical advice or a treatment guarantee; any use should be under qualified physician supervision.

    Knee Osteoarthritis · Bayesian Network Meta-Analysis

    PRP ranked the highest-probability injectable across WOMAC domains

    Surface under the cumulative ranking curve (SUCRA) is the probability that a treatment is the top-ranked option, not an effect size. PRP ranked highest among ultrasound-guided injectables (PRP > hyaluronic acid > corticosteroid). Zhang J, et al., Frontiers in Medicine, 2025 — Bayesian network meta-analysis of 14 randomized controlled trials (934 patients) in early-to-mid-stage knee osteoarthritis.

    Key references: PRP vs hyaluronic acid, corticosteroid or saline for knee OA (62 RCTs) — International Orthopaedics (2026) · Ultrasound-guided injections for knee OA: Bayesian network meta-analysis — Frontiers in Medicine (2025) · Efficacy of PRP injections in knee OA: systematic review & meta-analysis — Cureus (2025) · Leukocyte-poor PRP and reduced retear after rotator cuff repair — Arthroscopy (2025) · PRP in the management of alopecia: systematic review & meta-analysis — Dermatology and Therapy (2025) · PRP and hair density in androgenetic alopecia: meta-analysis — Anais Brasileiros de Dermatologia (2024)

    Interactions & Precautions

    Contraindications

    • Active infection
    • Blood disorders
    • Anticoagulation
    • Cancer at injection site

    Potential Risks

    • •Infection
    • •Nerve damage if improperly placed
    • •Limited effect in severe degeneration

    Potential Side Effects

    Injection site pain
    Temporary swelling
    Bruising
    Rare: infection

    Practitioner Notes

    Clinical annotations from Dr. Goel

    Quality of PRP varies significantly by preparation system. Leukocyte-rich vs leukocyte-poor depends on indication. Combine with other regenerative therapies.
    SG

    Dr. Sanjeev Goel

    Chief Medical Officer, Peak Human

    Cost & Access

    Cost Range

    $$

    Accessibility

    Widely available

    Availability varies by location

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation